TScan Therapeutics, Inc. (TCRX)
TScan Therapeutics Market Cap: 64.69M for Jan. 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| GT Biopharma, Inc. | 7.764M |
| Alnylam Pharmaceuticals, Inc. | 47.46B |
| Geron Corp. | 829.86M |
| Novavax, Inc. | 1.264B |
| XOMA Royalty Corp. | 356.51M |
Market Cap Related Metrics
| PS Ratio | 17.26 |
| Price to Book Value | 0.4492 |
| Price | 1.14 |
| Earnings Yield | -98.20% |